Exceeding the limit of impurity 5-[4'-[(5-(azidomethyl)-2-butyl-4-chloro-1H-imidazol-1-yl)methyl]-[1,1'-biphenyl]-2-yl]-1H-tetrazole was found in the active substance used to manufacture the tablets. Potential effects: possible toxic effects and lack of full therapy safety.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use tablets from the listed batches, check the batch number on the packaging, return the product to the pharmacy if you have it, and consult a doctor in case of doubts or adverse symptoms.
The Lakea batches KW1650, LG4000 and LG4001 were withdrawn from the market nationwide and the decision was given immediate enforceability.
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related